__NUXT_JSONP__("/drugs/Acridine_Carboxamide", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"A tricyclic acridine-based (or carboxamide-based) drug with dual topoisomerase inhibitor and potential antineoplastic activities. Acridine carboxamide inhibits both topoisomerases I and II and intercalates into DNA, resulting in DNA damage, the disruption of DNA repair and replication, the inhibition of RNA and protein synthesis, and cell death.",fdaUniiCode:"0N3V8R4E13",identifier:"C2203",preferredName:c,semanticType:"Organic Chemical",subclassOf:["C1968","C582"],synonyms:["ACRIDINE CARBOXAMIDE",c,"DACA","N-(2-(Dimehtylamino)ethyl)acridine-4-carboxamide","SN 22995","XR5000","acridine carboxamide"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FAcridine_Carboxamide",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","Acridine_Carboxamide","Acridine Carboxamide","2021-10-30T13:37:20.313Z")));